期刊文献+

多发性骨髓瘤中c-myc和MDM2蛋白的表达及其临床意义 被引量:21

Expression of c-myc and MDM2 protein in multiple myeloma and their clinical significance
下载PDF
导出
摘要 目的探讨c-myc蛋白及小鼠双微体基因(murine double minute 2,MDM2)蛋白在多发性骨髓瘤(multiple myeloma,MM)中的表达及其与临床分期的相关性。方法采用免疫组化SP三步法检测60例不同临床分期MM组织和10例非肿瘤骨髓组织中c-myc蛋白及MDM2蛋白的表达。结果 c-myc蛋白在MM及非肿瘤骨髓组织中的阳性率分别为71.7%、10.0%,MDM2蛋白在MM及非肿瘤骨髓组织中的阳性率分别为80.0%、20.0%,两者在MM及非肿瘤骨髓组织中的表达差异有统计学意义(P<0.05)。两者表达与MM的临床分期呈正相关性(P<0.05),与MM患者性别、年龄无相关性。MM中c-myc蛋白和MDM2蛋白的表达呈正相关(P<0.05)。结论 c-myc蛋白和MDM2蛋白在MM中高表达,其可能与MM的发生及临床分期有关;在MM中,c-myc蛋白和MDM2蛋白可能具有协同作用,共同促进肿瘤的发展。 Purpose To investigate the expression of c-myc and MDM2 protein in multiple myeloma (MM) and their correlation with clinical stage. Methods Immunohistochemical SP three-step method was used to detect the expression of MDM2 and c-myc protein in 60 cases of MM with different clinical stages and 10 cases of nontumorous bone marrow tissue. Results The positive rate of c-myc protein in MM and nontumorous bone marrow tissue were 71.7% and 10. 0%; the positive rate of MDM2 protein in two tissues were 80. 0% and 20. 0% , respectively. The expression difference of two proteins between MM and nontumorous bone marrow tissue was statistically significant (P 〈 0. 05 ). The expression of c-myc and MDM2 protein was positively correlated with MM clinical ISS stage ( P 〈 0. 05 ) , but irrelevant with the age and gender. The expression of c-myc and MDM2 protein in MM was positively correlated ( P 〈 0. 05 ). Conclusion The c-myc and MDM2 protein have a highly expression in MM, and it may he relative to the occurrence of MM and clinical stage. In the MM, c-myc and MDM2 protein may have synergetic functions and promote the development of tumor.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2017年第2期165-168,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 河南省高等学校重点科研项目(17A310036)
关键词 骨肿瘤 多发性骨髓瘤 C-MYC蛋白 MDM2蛋白 临床分期 bone neoplasms multiple myeloma c-myc protein MDM2 protein clinical stage
  • 相关文献

参考文献3

二级参考文献130

  • 1FU Qiang.Huge retroperitoneal liposarcoma:a case report[J].Chinese Medical Journal,2007(12):1117-1118. 被引量:7
  • 2Cahilly-Snyder L, Yang-Feng T, Francke U and George DL. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 1987, 13: 235-244.
  • 3Fakharzadeh SS, Trusko SP and George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 1991, 10: 1565-1569.
  • 4Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 1998, 17: 554-564.
  • 5Zhang Y and Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16: 369-377.
  • 6Lindstrom MS, Jin A, Deisenroth C, White Wolf G and Zhang Y. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Bioi 2007, 27: 1056-1068.
  • 7Boddy MN, Freemont PS and Borden KL. The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem Sci 1994, 19: 198-199.
  • 8Honda R, Tanaka H and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressorp53. FEBS Lett 1997, 420: 25-27.
  • 9Poyurovsky MV, Priest C, Kentsis A, Borden KL, Pan ZQ, Pavletich N and Prives C. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J 2007, 26: 90-101.
  • 10Thrower JS, Hoffman L, Rechsteiner M and Pickart CM. Recognition of the polyubiquitin proteolytic signal. EMBO J 2000, 19: 94-102.

共引文献59

同被引文献115

引证文献21

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部